BlackRock Health Sciences Trust (NYSE:BME) Stock Price Crosses Above 50 Day Moving Average – Here’s Why

BlackRock Health Sciences Trust (NYSE:BME)’s stock price passed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of $43.69 and traded as high as $45.91. BlackRock Health Sciences Trust shares last traded at $45.56, with a volume of 47,643 shares changing hands.

BlackRock Health Sciences Trust Stock Performance

The company’s 50-day moving average price is $43.79 and its 200-day moving average price is $41.33.

BlackRock Health Sciences Trust Dividend Announcement

The firm also recently declared a monthly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Tuesday, September 15th will be paid a $0.2621 dividend. The ex-dividend date is Tuesday, September 15th. This represents a c) dividend on an annualized basis and a yield of 6.9%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the business. Sound Income Strategies LLC purchased a new position in shares of BlackRock Health Sciences Trust in the 1st quarter valued at about $36,000. Northwestern Mutual Wealth Management Co. lifted its stake in BlackRock Health Sciences Trust by 22.2% during the third quarter. Northwestern Mutual Wealth Management Co. now owns 1,417 shares of the company’s stock worth $53,000 after purchasing an additional 257 shares during the last quarter. Geneos Wealth Management Inc. boosted its holdings in BlackRock Health Sciences Trust by 200.0% in the second quarter. Geneos Wealth Management Inc. now owns 4,899 shares of the company’s stock valued at $179,000 after purchasing an additional 3,266 shares in the last quarter. Fifth Third Bancorp purchased a new position in BlackRock Health Sciences Trust in the first quarter valued at approximately $180,000. Finally, Money Concepts Capital Corp acquired a new stake in BlackRock Health Sciences Trust during the first quarter worth approximately $209,000.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.